» Articles » PMID: 38476536

Value of Procalcitonin and Presepsin in the Diagnosis and Severity Stratification of Sepsis and Septic Shock

Overview
Specialty Emergency Medicine
Date 2024 Mar 13
PMID 38476536
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Pivotal Role of Presepsin in Assessing Sepsis-Induced Cholestasis.

Ghenu M, Dragos D, Manea M, Balcangiu-Stroescu A, Ionescu D, Negreanu L Diagnostics (Basel). 2024; 14(16).

PMID: 39202194 PMC: 11353418. DOI: 10.3390/diagnostics14161706.

References
1.
Xiao H, Wang G, Wang Y, Tan Z, Sun X, Zhou J . Potential Value of Presepsin Guidance in Shortening Antibiotic Therapy in Septic Patients: a Multicenter, Prospective Cohort Trial. Shock. 2021; 57(1):63-71. DOI: 10.1097/SHK.0000000000001870. View

2.
Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A . Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Med. 2014; 41(1):12-20. DOI: 10.1007/s00134-014-3514-2. View

3.
Ulla M, Pizzolato E, Lucchiari M, Loiacono M, Soardo F, Forno D . Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013; 17(4):R168. PMC: 4056762. DOI: 10.1186/cc12847. View

4.
Schuetz P, Maurer P, Punjabi V, Desai A, Amin D, Gluck E . Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013; 17(3):R115. PMC: 4057444. DOI: 10.1186/cc12787. View

5.
Rudd K, Johnson S, Agesa K, Shackelford K, Tsoi D, Kievlan D . Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395(10219):200-211. PMC: 6970225. DOI: 10.1016/S0140-6736(19)32989-7. View